Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.4157
-0.0350-7.77%
Post-market: 0.4113-0.0044-1.06%19:20 EDT
Volume:431.75K
Turnover:182.05K
Market Cap:25.76M
PE:-0.44
High:0.4502
Open:0.4464
Low:0.4107
Close:0.4507
Loading ...

Cognition Therapeutics’ Analysis Correlates Biomarker Changes with Cognitive Benefit in Alzheimer’s Population

GlobeNewswire
·
25 Nov 2024

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire
·
15 Nov 2024

Cognition Therapeutics reports Q3 EPS (25c), consensus (22c)

TIPRANKS
·
13 Nov 2024

Cognition Therapeutics sees cash runway into 2Q25

TIPRANKS
·
13 Nov 2024

Cognition Therapeutics - Qtrly Loss per Share $0.25

THOMSON REUTERS
·
13 Nov 2024

Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

GlobeNewswire
·
13 Nov 2024

Life Sciences Investor Forum Agenda Announced for November 14th

GlobeNewswire
·
12 Nov 2024

Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum

GlobeNewswire
·
12 Nov 2024

Cognition Therapeutics (CGTX) Gets a Buy from Oppenheimer

TIPRANKS
·
05 Nov 2024

Cognition Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Nov 2024

Positive Buy Rating Reaffirmed for Cognition Therapeutics Amid Promising Alzheimer’s Drug Data

TIPRANKS
·
04 Nov 2024

Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD

GlobeNewswire
·
01 Nov 2024

Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD

GlobeNewswire
·
30 Oct 2024

Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Executing Clinical Research in Dementia with Lewy Bodies (DLB)

GlobeNewswire
·
22 Oct 2024

Cognition Therapeutics Inc (CGTX) Q2 2024 Earnings Call Highlights: Promising Alzheimer's Trial ...

GuruFocus.com
·
10 Oct 2024

Cognition Therapeutics Will Participate in the Roth Healthcare Opportunities Conference

GlobeNewswire
·
02 Oct 2024